Medicare Enrolled

Dr. Javaid Sheikh, MD FACP MRCP UK

Rheumatology · Orlando, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
58 W MICHIGAN ST, Orlando, FL 32806
4076509220
In practice since 2005 (20 years)
NPI: 1942281357 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sheikh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheikh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sheikh

Dr. Javaid Sheikh is a rheumatology specialist in Orlando, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sheikh performed 97,457 Medicare services across 4,217 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sheikh received a total of $14,578 from 36 pharmaceutical and/or device companies across 920 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sheikh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 25% volume in FL $14,578 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 71269 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
97,457
Medicare services
Top 25% in FL for rheumatology
4,217
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,873 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia) 80,400 $4 $12
Abatacept infusion (Orencia) 9,400 $33 $70
Office visit, established patient (30-39 min) 746 $93 $180
Office visit, established patient (20-29 min) 553 $62 $120
X-ray of wrist, minimum of 3 views 540 $32 $65
X-ray of hand, minimum of 3 views 540 $29 $60
X-ray of knee, 4 or more views 536 $36 $70
X-ray of elbow, minimum of 3 views 534 $25 $65
Shoulder X-ray, 2+ views 528 $27 $55
X-ray of ankle, minimum of 3 views 528 $29 $60
Foot X-ray, 3+ views 528 $27 $55
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 427 $56 $100
X-ray of both hips, 3-4 views 266 $40 $70
X-ray of lower and sacral spine, minimum of 4 views 265 $38 $80
X-ray of upper spine, 2-3 views 264 $31 $70
X-ray of middle spine, 2 views 262 $26 $54
X-ray of joint between lower spine and hip bone, 3 or more views 262 $31 $60
Office visit, established patient, complex (40-54 min) 135 $130 $250
Bone density scan (DEXA) 134 $37 $149
Injection, methylprednisolone sodium succinate, up to 125 mg 126 $4 $10
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 125 $21 $50
Administration of chemotherapy into vein, 1 hour or less 117 $96 $250
Injection, methylprednisolone acetate, 40 mg 53 $6 $15
New patient office visit, complex (60-74 min) 46 $165 $298
Telephone medical discussion with physician, 21-30 minutes 44 $88 $150
New patient office visit (45-59 min) 33 $116 $250
Joint injection, major joint 26 $48 $110
Blood draw (venipuncture) 23 $7 $8
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 16 $49 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
83.3% medium
6.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,578
Total received (2018-2024)
Avg $2,083/year across 7 years
Top 34% in FL for rheumatology
36
Companies
920
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,578 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,488
2023
$2,344
2022
$1,678
2021
$2,164
2020
$2,009
2019
$2,019
2018
$1,876

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,247
UCB, Inc.
$2,399
PFIZER INC.
$2,369
Novartis Pharmaceuticals Corporation
$1,863
E.R. Squibb & Sons, L.L.C.
$1,004
Lilly USA, LLC
$660
AstraZeneca Pharmaceuticals LP
$509
Aurinia Pharma U.S., Inc.
$331
ABBVIE INC.
$244
Boehringer Ingelheim Pharmaceuticals, Inc.
$242
AbbVie, Inc.
$228
GlaxoSmithKline, LLC.
$203
AbbVie Inc.
$178
Horizon Therapeutics plc
$157
Fresenius Kabi USA, LLC
$139
Celgene Corporation
$125
Janssen Biotech, Inc.
$113
Organon Llc
$102
GENZYME CORPORATION
$77
Organon LLC
$60
TerSera Therapeutics LLC
$45
Mallinckrodt Hospital Products Inc.
$32
Sandoz Inc.
$27
Sobi, Inc
$26
Actelion Pharmaceuticals US, Inc.
$25
Janssen Pharmaceuticals, Inc
$20
Ironwood Pharmaceuticals, Inc
$19
SOBI, INC
$19
Kyowa Kirin, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$16
Merck Sharp & Dohme Corporation
$15
Genentech USA, Inc.
$14
US Oncology Corporate, Inc.
$14
Horizon Pharma plc
$13
West-Ward Pharmaceuticals
$12
Sebela Pharmaceuticals Inc.
$12
Top 3 companies account for 55.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · Enbrel · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · Kineret · LUPKYNIS · Mitigare · OFEV · OPSUMIT · ORENCIA · Otezla · PENNSAID · PRIALT · QMIIZ ODT · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rinvoq · SAPHNELO · SIMPONI ARIA · SKYRIZI · Seglentis · TALTZ · TAVNEOS · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $15 per 100 Medicare services performed
Looking for a rheumatology specialist in Orlando?
Compare rheumatologists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
41
Per 100K population
2.8
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sheikh is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sheikh experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Sheikh performed 80,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sheikh receive payments from pharmaceutical companies?
Yes. Dr. Sheikh received a total of $14,578 from 36 companies across 920 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sheikh's costs compare to other rheumatologists in Orlando?
Dr. Sheikh's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sheikh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →